drugset / Trial / NCT03220191
Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib
SequentialOpen-labelBasic science
Summary
to evaluate the effect of the PPI (rabeprazole) on the PK of a potential commercial tablet formulation of palbociclib
Timeline
- Start
- 2017-07-21
- Primary completion
- 2017-09-03
- Completion
- 2017-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palbociclib | Small molecule | — | — |
| Subject | Rabeprazole | Small molecule | — | — |
Indications
No indication recorded.